WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, Q.
Right arrow Articles by Garris, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Q.
Right arrow Articles by Garris, P. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 15, 2002, 22(14):6272-6281

Concurrent Autoreceptor-Mediated Control of Dopamine Release and Uptake during Neurotransmission: An In Vivo Voltammetric Study

Qun Wu1, Maarten E. A. Reith2, Q. David Walker3, Cynthia M. Kuhn3, F. Ivy Carroll4, and Paul A. Garris1, 2

1 Cellular and Integrative Physiology Section, Department of Biological Sciences, Illinois State University, Normal, Illinois 61790, 2 Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine at Peoria, Peoria, Illinois 61656, 3 Department of Pharmacology, Duke University Medical School, Durham, North Carolina 27710, and 4 Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, North Carolina 27709

Receptor-mediated feedback control plays an important role in dopamine (DA) neurotransmission. Recent evidence suggests that release and uptake, key mechanisms determining brain extracellular levels of the neurotransmitter, are governed by presynaptic autoreceptors. The goal of this study was to investigate whether autoreceptors regulate both mechanisms concurrently. Extracellular DA in the caudate-putamen and nucleus accumbens, evoked by electrical stimulation of the medial forebrain bundle, was monitored in the anesthetized rat by real-time voltammetry. Effects of the D2 antagonist haloperidol (0.5 mg/kg, i.p.) on evoked DA levels were measured to evaluate autoreceptor control mechanisms. Two strategies were used to resolve individual contributions of release and uptake to the robust increases in DA signals observed after acute haloperidol challenge in naive animals: pretreatment with 3beta -(p-chlorophenyl)tropan-2beta -carboxylic acid p-isothiocyanatophenylmethyl ester hydrochloride (RTI-76; 100 nmol, i.c.v.), an irreversible inhibitor of the DA transporter, and kinetic analysis of extracellular DA dynamics. RTI-76 effectively removed the uptake component from recorded signals. In RTI-76-pretreated rats, haloperidol induced only modest increases in DA elicited by low frequencies and had little or no effect at high frequencies. These results suggest that D2 antagonism alters uptake at all frequencies but only release at low frequencies. Kinetic analysis similarly demonstrated that haloperidol decreased Vmax for DA uptake and increased DA release at low (10-30 Hz) but not high (40-60 Hz) stimulus frequencies. We conclude that presynaptic DA autoreceptors concurrently downregulate release and upregulate uptake, and that the mechanisms are also independently controlled during neurotransmission.

Key words: dopamine; autoreceptors; release; uptake; striatum; voltammetry


Copyright © 2002 Society for Neuroscience  0270-6474/02/22146272-10$05.00/0


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. Zhang, W. M. Doyon, J. J. Clark, P. E. M. Phillips, and J. A. Dani
Controls of Tonic and Phasic Dopamine Transmission in the Dorsal and Ventral Striatum
Mol. Pharmacol., August 1, 2009; 76(2): 396 - 404.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Nikolaus, C. Antke, K. Kley, M. Beu, A. Wirrwar, and H.-W. Muller
Pretreatment with Haloperidol Reduces 123I-FP-CIT Binding to the Dopamine Transporter in the Rat Striatum: An In Vivo Imaging Study with a Dedicated Small-Animal SPECT Camera
J. Nucl. Med., July 1, 2009; 50(7): 1147 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. J. Aragona, N. A. Cleaveland, G. D. Stuber, J. J. Day, R. M. Carelli, and R. M. Wightman
Preferential Enhancement of Dopamine Transmission within the Nucleus Accumbens Shell by Cocaine Is Attributable to a Direct Increase in Phasic Dopamine Release Events
J. Neurosci., August 27, 2008; 28(35): 8821 - 8831.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
M. J Frank, A. Scheres, and S. J Sherman
Understanding decision-making deficits in neurological conditions: insights from models of natural action selection
Phil Trans R Soc B, September 29, 2007; 362(1485): 1641 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Akopian and J. P. Walsh
Reliable long-lasting depression interacts with variable short-term facilitation to determine corticostriatal paired-pulse plasticity in young rats
J. Physiol., April 1, 2007; 580(1): 225 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Rodriguez, I. Morales, I. Gomez, S. Gonzalez, T. Gonzalez-Hernandez, and J. L. Gonzalez-Mora
Heterogeneous Dopamine Neurochemistry in the Striatum: The Fountain-Drain Matrix
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 31 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. J. Porrino, D. Lyons, H. R. Smith, J. B. Daunais, and M. A. Nader
Cocaine Self-Administration Produces a Progressive Involvement of Limbic, Association, and Sensorimotor Striatal Domains
J. Neurosci., April 7, 2004; 24(14): 3554 - 3562.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T.-A. Ansah, S. Ramamoorthy, S. Montanez, L. C. Daws, and R. D. Blakely
Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the {alpha}2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304)
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 956 - 965.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-